Hillstream BioPharma (HILS) News Today

$0.38
+0.01 (+2.71%)
(As of 04/23/2024 ET)
SourceHeadline
morningstar.com logoHill & Smith PLC HILS
morningstar.com - April 17 at 7:23 PM
morningstar.com logoKiromic BioPharma Inc Ordinary Shares KRBP
morningstar.com - October 31 at 6:02 PM
finance.yahoo.com logoHillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.
finance.yahoo.com - September 22 at 12:10 PM
finance.yahoo.com logoDawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
finance.yahoo.com - September 21 at 9:45 AM
finance.yahoo.com logoHillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis
finance.yahoo.com - September 11 at 4:50 PM
finance.yahoo.com logoHillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
finance.yahoo.com - September 8 at 6:19 PM
benzinga.com logoHillstream – Drug Maker Licenses Critical New Technology In Fight Against Cancer
benzinga.com - August 30 at 6:07 PM
seekingalpha.com logoNMTRQ 9 Meters Biopharma, Inc.
seekingalpha.com - August 25 at 10:22 AM
finance.yahoo.com logoHillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023
finance.yahoo.com - August 9 at 9:10 AM
finance.yahoo.com logoHillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215
finance.yahoo.com - July 20 at 9:23 AM
finance.yahoo.com logoHillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologics
finance.yahoo.com - July 10 at 1:07 PM
finance.yahoo.com logoHillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers
finance.yahoo.com - July 6 at 10:42 AM
finance.yahoo.com logoHILS - Hillstream BioPharma, Inc.
finance.yahoo.com - June 9 at 8:05 PM
finance.yahoo.com logoHillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson
finance.yahoo.com - May 15 at 10:45 AM
finanznachrichten.de logoHillstream BioPharma, Inc.: Hillstream BioPharma Announces Closing of Public Offering of Common Stock
finanznachrichten.de - May 4 at 1:01 AM
finance.yahoo.com logoHillstream BioPharma Announces Closing of Public Offering of Common Stock
finance.yahoo.com - May 2 at 5:56 PM
finance.yahoo.com logoHillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences
finance.yahoo.com - May 2 at 12:55 PM
benzinga.com logoHillstream BioPharma Stock (NASDAQ:HILS), Short Interest Report
benzinga.com - April 29 at 1:39 PM
finanznachrichten.de logoHillstream BioPharma, Inc.: Hillstream BioPharma Announces Proposed Public Offering
finanznachrichten.de - April 28 at 6:18 PM
marketwatch.com logoHillstream BioPharma Shares Slide Premarket on Stock Offering >HILS
marketwatch.com - April 28 at 1:02 PM
investorplace.com logoWhy Is Hillstream BioPharma (HILS) Stock Down 57% Today?
investorplace.com - April 28 at 9:22 AM
finanznachrichten.de logoHillstream BioPharma, Inc.: Hillstream BioPharma Announces Pricing of Public Offering
finanznachrichten.de - April 28 at 7:41 AM
finance.yahoo.com logoHillstream BioPharma Announces Pricing of Public Offering
finance.yahoo.com - April 27 at 11:45 PM
finance.yahoo.com logoHillstream BioPharma Announces Proposed Public Offering
finance.yahoo.com - April 27 at 6:44 PM
tmcnet.com logoHillstream BioPharma Selects OncoBay Clinical to Advance Clinical
tmcnet.com - April 13 at 2:08 PM
finance.yahoo.com logoHillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism
finance.yahoo.com - April 13 at 9:07 AM
finance.yahoo.com logoHillstream BioPharma’s Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
finance.yahoo.com - April 12 at 1:06 PM
benzinga.com logoHillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
benzinga.com - April 11 at 11:00 AM
finance.yahoo.com logoHillstream BioPharma Announces Pharmacokinetic Data of HSB-1216 Supportive of its Development Strategy and Pre-clinical Data
finance.yahoo.com - April 10 at 1:21 PM
finance.yahoo.com logoHillstream BioPharma to Participate in Two Major Industry Conferences in April 2023
finance.yahoo.com - March 28 at 10:38 AM
finance.yahoo.com logoHillstream BioPharma to Attend the 35th Annual ROTH Conference on March 12-14, 2023
finance.yahoo.com - February 28 at 8:02 PM
finance.yahoo.com logoHillstream BioPharma Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
finance.yahoo.com - February 15 at 8:56 AM
finance.yahoo.com logoHillstream BioPharma Provides Webcast for its R&D Day on February 14th, 2023 at 10:00am ET
finance.yahoo.com - February 13 at 8:25 PM
finance.yahoo.com logoHillstream BioPharma Signs Exclusive Option Agreement with Applied Biomedical Science Institute (ABSI) to License Technology for HER2 and HER3 to be Developed for Potential Treatments Against Drug Resistant Cancers Including HER2-Positive Metastatic Breast Cancer, Gastric Cancer, Lung Cancer and Ovarian Cancer
finance.yahoo.com - February 13 at 10:24 AM
baystreet.ca logoHillstream Nearly Doubles on Test Results
baystreet.ca - February 10 at 12:41 PM
msn.com logoHillstream Soars on Promising HSB-1216 Data in Lung Cancer
msn.com - February 10 at 12:41 PM
finance.yahoo.com logoIn a KRAS G12C-mutated NSCLC cell line, Calu-1, Hillstream BioPharma Demonstrated Significantly Greater Tumor Inhibition Combining Pembrolizumab, an anti-PD-1 antibody, and HSB-1216, a Ferroptosis Inducer
finance.yahoo.com - February 10 at 7:34 AM
finance.yahoo.com logoHillstream BioPharma Announces Acceptance of Abstract at AACR 2023 Annual Meeting Highlighting HSB-510 as Novel Bi-functional Inhibitor for Solid Tumors & Leukemias
finance.yahoo.com - February 8 at 8:42 AM
finance.yahoo.com logoHillstream BioPharma to Host Virtual R&D Day to Showcase its Emerging Immuno-oncology Pipeline Targeting Drug-Resistant Cancers
finance.yahoo.com - February 6 at 9:46 AM
finance.yahoo.com logoWhy Are Hillstream BioPharma Shares Trading Over 100% Today?
finance.yahoo.com - January 31 at 2:47 PM
finance.yahoo.com logoHillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers
finance.yahoo.com - January 31 at 9:46 AM
marketbeat.com logo
marketbeat.com - January 31 at 9:37 AM
finance.yahoo.com logoHillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023
finance.yahoo.com - January 17 at 4:04 PM
finance.yahoo.com logoInsiders who purchased Hillstream BioPharma, Inc. (NASDAQ:HILS) stock last year recover some losses which currently stand at US$86k
finance.yahoo.com - December 12 at 7:20 AM
marketbeat.com logo
marketbeat.com - December 9 at 10:49 AM
finance.yahoo.com logoHillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targets
finance.yahoo.com - December 1 at 9:17 AM
finance.yahoo.com logoHillstream’s New Anti-Cancer Mechanism Quatramer-based Ferroptosis Inducer, HSB-1216 Abstract Available for Viewing at EORTC-NCI-AACR Symposium
finance.yahoo.com - October 18 at 6:14 PM
finance.yahoo.com logoHillstream BioPharma, Inc. to Present at Upcoming Investor Conferences
finance.yahoo.com - October 6 at 11:03 AM
finance.yahoo.com logoHillstream BioPharma, Inc. (HILS)
finance.yahoo.com - September 21 at 10:10 PM
benzinga.com logoHillstream BioPharma to Participate in the Fierce...
benzinga.com - September 16 at 10:59 AM
Get Hillstream BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter.

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

HILS Media Mentions By Week

HILS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HILS
News Sentiment

0.00

0.43

Average
Medical
News Sentiment

HILS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HILS Articles
This Week

1

0

HILS Articles
Average Week

Get Hillstream BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HILS) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners